Stay updated on Avelumab Combo Regimens in R/R DLBCL Clinical Trial

Sign up to get notified when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T14:14:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice was added announcing changes to NIH terminology and linking to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:32:44.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:55:49.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-11T15:23:14.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study record is still unavailable, with the page displaying a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-04T16:43:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a basic header and the text 403 Forbidden, indicating restricted access to the study record. This replaces the usual study content with an error page, signaling an access issue.
    Difference
    22%
    Check dated 2026-09-20T12:33:41.000Z thumbnail image

Stay in the know with updates to Avelumab Combo Regimens in R/R DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.